Beam Therapeutics Inc header image

Beam Therapeutics Inc

BEAM

Equity

ISIN null / Valor 50337226

NASDAQ (2026-02-26)
USD 28.92-2.33%

Beam Therapeutics Inc
UMushroom community rating:

star star star star star
4.00 4 votes No rating yet
NegativeNeutralPositive

About company

Beam Therapeutics Inc is a biotechnology company focused on developing innovative gene editing technologies to treat a wide range of genetic diseases. The company's delivery strategy involves utilizing a suite of clinically validated technologies, including electroporation, nonviral, and viral delivery modalities, to efficiently and precisely edit genes. Beam Therapeutics Inc aims to revolutionize the field of gene editing by providing novel solutions for patients with genetic disorders.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

3.69%1Y
-25.7%3Y
-67.6%5Y

Performance

78.0%1Y
71.0%3Y
76.1%5Y

Volatility

Market cap

2935 M

Market cap (USD)

Daily traded volume (Shares)

3,041,913

Daily traded volume (Shares)

1 day high/low

26.41 / 24.77

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

4 votes
Performance:
starstarstarstarstar
3.79
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.14
Nature:
starstarstarstarstar
2.79
Fabio Kull
Switzerland, 30 Oct 2025
star star star star star
promising biotech company focused on precise gene editing. The stock is innovative but risky
Carlos Mayes
United Kingdom, 21 Oct 2025
star star star star star
Strong growth currently
Ben Marshall
United Kingdom, 21 Oct 2025
star star star star star
Currently performing very well however has potential to fall off completely soon

EQUITIES OF THE SAME SECTOR

Exclusive Networks
Exclusive Networks Exclusive Networks Valor: 113743361
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 18.96
JOYY Inc
JOYY Inc JOYY Inc Valor: 51728275
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%USD 62.81
Zai Lab Ltd
Zai Lab Ltd Zai Lab Ltd Valor: 38178853
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.55%USD 19.69
Betsson AB
Betsson AB Betsson AB Valor: 138068306
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.45%SEK 93.95
DXC Technology Company
DXC Technology Company DXC Technology Company Valor: 35991811
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.90%USD 12.64
BioNTech SE
BioNTech SE BioNTech SE Valor: 50030055
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%USD 108.80
MKS Instruments Inc
MKS Instruments Inc MKS Instruments Inc Valor: 616689
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.39%USD 244.68
Nebius Group N.V.
Nebius Group N.V. Nebius Group N.V. Valor: 12955842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.17%USD 104.88
Rapid7 Inc
Rapid7 Inc Rapid7 Inc Valor: 28570046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.91%USD 6.39
Progress Software Corp
Progress Software Corp Progress Software Corp Valor: 963966
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.63%USD 42.09